Sasmar Pharmaceuticals SRL
0.7 FTESasmar Pharmaceuticals reported revenue of €1.78m for the 2025 financial year (annual accounts filed with the NBB on 07 Oct 2026), with 0.7 full-time equivalent.
The score of Sasmar Pharmaceuticals shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +35 % Total assets +87 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sasmar Pharmaceuticals's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €1.78m | ||||
| Net result | 133,640 € | ||||
| Equity | 379,779 € | ||||
| Cash | 2,917 € | ||||
| EBITDA | 140,545 € | ||||
| Total assets | €3.07m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Oct 2026
- Year ended 31 Dec 2024filed on 26 Sep 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 18 Sep 2023
- Year ended 31 Dec 2021filed on 05 Sep 2022
Sasmar Pharmaceuticals's financial analysis
- Solvency12.4%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sasmar Pharmaceuticals
Sasmar Pharmaceuticals's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0507.657.022
- VAT number
- BE0507657022
- Peppol
- Registered · 0208:0507657022 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Dec 2014
- Registered office
- 3090 Overijse
- Size
- Micro · 0.7 FTE
- Latest accounts
- 2025 · filed on 07 Oct 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Sasmar Pharmaceuticals (SRL) has been based in Overijse since 2014, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €1.78m, a net profit of 133,640 € and equity of 379,779 €. With 0.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 12.4%, below the median of its sector (46.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sasmar Pharmaceuticals
Companies in the same business, of comparable size and area, outside its group.
- Cirba Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 67,062 €
- Arkopharma Belux Wholesale of pharmaceutical and medical goods Wavre · balance sheet €5.33m
- Alexion Pharma Belgium Manufacture of pharmaceutical preparations Brussels · balance sheet €8.68m
- Surveal Pharma Wholesale of pharmaceutical and medical goods Ixelles · balance sheet €5.47m
- Stylepharma Wholesale of pharmaceutical and medical goods Waterloo · balance sheet 503,082 €
- Biogen Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €25.5m
- Mathi Medical Wholesale of pharmaceutical and medical goods Lasne · balance sheet 418,269 €
- Schwabe Pharma Belgium Wholesale of pharmaceutical and medical goods Kontich · balance sheet €3.13m
Frequently asked questions about Sasmar Pharmaceuticals
What is the revenue of Sasmar Pharmaceuticals?
According to the 2025 annual accounts filed with the NBB, the revenue of Sasmar Pharmaceuticals amounts to 1,777,061 €.
What is the VAT number of Sasmar Pharmaceuticals?
In Belgium, the VAT number is the company number prefixed with BE: BE0507657022 for Sasmar Pharmaceuticals, if the company is VAT-registered. Its company number (CBE) is 0507.657.022.
Where is the registered office of Sasmar Pharmaceuticals?
According to the CBE register, the registered office of Sasmar Pharmaceuticals is in 3090 Overijse.
What is the equity of Sasmar Pharmaceuticals?
At the close of the 2025 financial year, the equity of Sasmar Pharmaceuticals amounts to 379,779 €, a solvency of 12.4% of total assets.
How many people work at Sasmar Pharmaceuticals?
0.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Sasmar Pharmaceuticals?
The register lists 2 active mandates at Sasmar Pharmaceuticals. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sasmar Pharmaceuticals
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →